Next 10 |
PARIS, FRANCE and CAMBRIDGE, MA / ACCESSWIRE / March 22, 2024 / Biophytis SA (Nasdaq:BPTS)(Euronext Growth Paris:ALBPS), ("Biophytis" or the "Company"), a clinical-stage biotechnology company specialized in the development of therapeutics that are aimed at slowing the degenerative processes asso...
2023-11-17 17:23:20 ET More on Biophytis Biophytis receives notice of delisting from Nasdaq Biophytis and Skyepharma sign partnership agreement for production of Sarconeos For further details see: Biophytis SA receives non compliance notice from Nasdaq
PARIS, FRANCE and CAMBRIDGE, MA / ACCESSWIRE / October 30,2023 / Biophytis SA (Nasdaq CM:BPTS)(Euronext Growth Paris:ALBPS), («Biophytis»), a clinical-stage biotechnology company specialized in the development of therapeutics that are aimed at slowing the degenerative processes associa...
2023-10-27 17:24:16 ET More on Biophytis Biophytis and Skyepharma sign partnership agreement for production of Sarconeos Seeking Alpha’s Quant Rating on Biophytis Historical earnings data for Biophytis Financial information for Biophytis For fu...
PARIS, FRANCE and CAMBRIDGE, MA / ACCESSWIRE / October 27, 2023 / Biophytis SA (NASDAQ CM:BPTS, Euronext Growth Paris:ALBPS), ("Biophytis"), a clinical-stage biotechnology company specialized in the development of therapeutics that are aimed at slowing the degenerative processes associated with ...
2023-09-29 16:58:27 ET DENVER, Colo., Sept 29, 2023 ( www.247marketnews.com )- It was like this week shot out of a canon. Monday We started the week by covering Biophytis SA (NASDAQ: BPTS) and Skyepharma signing a partnership agreement for the production of regulatory batche...
2023-09-28 11:15:39 ET More on Biophytis Biophytis and Skyepharma sign partnership agreement for production of Sarconeos Seeking Alpha’s Quant Rating on Biophytis Historical earnings data for Biophytis Financial information for Biophytis For fu...
2023-09-28 08:24:45 ET More on Ascent Solar Technologies, Cardiff Oncology, etc. Cardiff Oncology (CRDF) Investor Presentation - Slideshow Cardiff Oncology: How The Recommitment Shapes The Investment Thesis (Rating Upgrade) Biggest stock movers today: Cloudflare, Nex...
Start of industrial development of Sarconeos (BIO101) with a view to market access in severe forms of Covid-19 (COVA) Approvals to start the Phase 3 trial in the United States and Belgium in sarcopenia (SARA), a world first, opening up the prospect of partnerships Cash position and secu...
2023-09-26 08:45:42 ET Palm Beach, FL – September 26, 2023 – FinancialNewsMedia.com News Commentary – There has been a rise in the prevalence of cancer in the past several years. Overall, there is a rapid increase in the prevalence of cancer cases and its gr...
News, Short Squeeze, Breakout and More Instantly...
Biophytis SA Company Name:
BPTS Stock Symbol:
NASDAQ Market:
Shares of Salarius Pharmaceuticals, Inc. (NASDAQ: SLRX) rose sharply in today’s pre-market trading following fourth-quarter results. Salariu...
PARIS, FRANCE and CAMBRIDGE, MA / ACCESSWIRE / March 22, 2024 / Biophytis SA (Nasdaq:BPTS)(Euronext Growth Paris:ALBPS), ("Biophytis" or the "Company"), a clinical-stage biotechnology company specialized in the development of therapeutics that are aimed at slowing the degenerative processes asso...
Shares of FactSet Research Systems Inc. (NYSE: FDS) fell sharply during Thursday’s session after the company reported worse-than-expected se...